Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
32
ITIC Quote, Financials, Valuation and Earnings
Last price:
$202.27
Seasonality move
:
1.28%
Day range:
$202.30 - $204.70
52-week range:
$189.45 - $290.40
Dividend yield:
0.91%
P/E ratio:
12.89x
P/S ratio:
1.47x
P/B ratio:
1.50x
Volume:
29.5K
Avg. volume:
70.5K
1-year change:
1.9%
Market cap:
$381.6M
Revenue:
$258.3M
EPS (TTM):
$15.70
Investors Title SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
ITIC
Investors Title
|
05/08/2024 | 10-Q | 10-Q filing on 05/08/2024 | View Form |
|
ITIC
Investors Title
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
ITIC
Investors Title
|
08/09/2023 | 10-Q | 10-Q filing on 08/09/2023 | View Form |
|
ITIC
Investors Title
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
ITIC
Investors Title
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
ITIC
Investors Title
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
ITIC
Investors Title
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
ITIC
Investors Title
|
11/09/2021 | 10-Q | 10-Q filing on 11/09/2021 | View Form |
|
ITIC
Investors Title
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
ITIC
Investors Title
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
ITIC
Investors Title
|
11/09/2020 | 10-Q | 10-Q filing on 11/09/2020 | View Form |
|
ITIC
Investors Title
|
08/07/2020 | 10-Q | 10-Q filing on 08/07/2020 | View Form |
|
ITIC
Investors Title
|
05/08/2020 | 10-Q | 10-Q filing on 05/08/2020 | View Form |
|
ITIC
Investors Title
|
03/11/2020 | 10-K | 10-K filing on 03/11/2020 | View Form |
|
ITIC
Investors Title
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
ITIC
Investors Title
|
08/08/2019 | 10-Q | 10-Q filing on 08/08/2019 | View Form |
|
ITIC
Investors Title
|
05/08/2019 | 10-Q | 10-Q filing on 05/08/2019 | View Form |
|
ITIC
Investors Title
|
03/13/2019 | 10-K | 10-K filing on 03/13/2019 | View Form |
|
ITIC
Investors Title
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
ITIC
Investors Title
|
08/08/2018 | 10-Q | 10-Q filing on 08/08/2018 | View Form |
|
ITIC
Investors Title
|
05/10/2018 | 10-Q | 10-Q filing on 05/10/2018 | View Form |
|
ITIC
Investors Title
|
03/12/2018 | 10-K | 10-K filing on 03/12/2018 | View Form |
|
ITIC
Investors Title
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
ITIC
Investors Title
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
ITIC
Investors Title
|
05/08/2017 | 10-Q | 10-Q filing on 05/08/2017 | View Form |
|
ITIC
Investors Title
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
ITIC
Investors Title
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
ITIC
Investors Title
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
ITIC
Investors Title
|
05/06/2016 | 10-Q | 10-Q filing on 05/06/2016 | View Form |
|
ITIC
Investors Title
|
03/11/2016 | 10-K | 10-K filing on 03/11/2016 | View Form |
|
ITIC
Investors Title
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
ITIC
Investors Title
|
08/07/2015 | 10-Q | 10-Q filing on 08/07/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
